Selected publications
-
Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 Mutation.
New England Journal of Medicine.
2017
Academic Article
GET IT
Times cited: 93 -
A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: Results of Cancer and Leukemia Group B (CALGB) 90102.
Annals of Oncology.
2009
Academic Article
GET IT
Times cited: 87 -
Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207.
Annals of Oncology.
2008
Academic Article
GET IT
Times cited: 38